|
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12145/12927 (94%)
Visitors : 848958
Online Users : 1460
|
|
|
Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/11151
|
Title: | Cerebral ischemia and neuroregeneration |
Authors: | Lee, RHC;Lee, MHH;Wu, CYC;Silva, ACE;Possoit, HE;Hsieh, TH;Minagar, A;Lin, HW |
Contributors: | Institute of Cellular and Systems Medicine |
Abstract: | Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Although stroke (a form of cerebral ischemia)-related costs are expected to reach 240.67 billion dollars by 2030, options for treatment against cerebral ischemia/stroke are limited. All therapies except anti-thrombolytics (i.e., tissue plasminogen activator) and hypothermia have failed to reduce neuronal injury, neurological deficits, and mortality rates following cerebral ischemia, which suggests that development of novel therapies again st stroke/cerebral ischemia are urgently needed. Here, we discuss the possible mechanism(s) underlying cerebral ischemia-induced brain injury, as well as current and future novel therapies (i.e., growth factors, nicotinamide adenine dinucleotide, melatonin, resveratrol, protein kinase C isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells) as it relates to cerebral ischemia. |
Date: | 2018-03 |
Relation: | Neural Regeneration Research. 2018 Mar;13(3):373-385. |
Link to: | http://dx.doi.org/10.4103/1673-5374.228711 |
JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1673-5374&DestApp=IC2JCR |
Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000429374200001 |
Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85049833023 |
Appears in Collections: | [其他] 期刊論文
|
Files in This Item:
File |
Size | Format | |
ISI000429374200001.pdf | 329Kb | Adobe PDF | 328 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|